Literature DB >> 30786065

Crowdsourcing to delineate skin affected by chronic graft-vs-host disease.

Eric R Tkaczyk1,2,3, Joseph R Coco4, Jianing Wang5, Fuyao Chen1,2,3, Cheng Ye5, Madan H Jagasia6, Benoit M Dawant3,5, Daniel Fabbri4,5.   

Abstract

BACKGROUND: Estimating the extent of affected skin is an important unmet clinical need both for research and practical management in many diseases. In particular, cutaneous burden of chronic graft-vs-host disease (cGVHD) is a primary outcome in many trials. Despite advances in artificial intelligence and 3D photography, progress toward reliable automated techniques is hindered by limited expert time to delineate cGVHD patient images. Crowdsourcing may have potential to provide the requisite expert-level data.
MATERIALS AND METHODS: Forty-one three-dimensional photographs of three cutaneous cGVHD patients were delineated by a board-certified dermatologist. 410 two-dimensional projections of the raw photos were each annotated by seven crowd workers, whose consensus performance was compared to the expert.
RESULTS: The consensus delineation by four of seven crowd workers achieved the highest agreement with the expert, measured by a median Dice index of 0.7551 across all 410 images, outperforming even the best worker from the crowd (Dice index 0.7216). For their internal agreement, crowd workers achieved a median Fleiss's kappa of 0.4140 across the images. The time a worker spent marking an image had only weak correlation with the surface area marked, and very low correlation with accuracy. Percent of pixels selected by the consensus exhibited good correlation (Pearson R = 0.81) with the patient's affected surface area.
CONCLUSION: Crowdsourcing may be an efficient method for obtaining demarcations of affected skin, on par with expert performance. Crowdsourced data generally agreed with the current clinical standard of percent body surface area to assess cGVHD severity in the skin. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  body surface area; crowdsourcing; graft-vs-host disease; machine learning; photography; stem cell transplantation; three-dimensional imaging

Mesh:

Year:  2019        PMID: 30786065      PMCID: PMC6719554          DOI: 10.1111/srt.12688

Source DB:  PubMed          Journal:  Skin Res Technol        ISSN: 0909-752X            Impact factor:   2.365


  15 in total

1.  A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.

Authors:  Mary E D Flowers; Jane F Apperley; Koen van Besien; Ahmet Elmaagacli; Andrew Grigg; Vijay Reddy; Andrea Bacigalupo; Hans-Jochem Kolb; Luis Bouzas; Mauricette Michallet; H Miles Prince; Robert Knobler; Dennis Parenti; Jose Gallo; Hildegard T Greinix
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

2.  How I conduct a comprehensive chronic graft-versus-host disease assessment.

Authors:  Paul A Carpenter
Journal:  Blood       Date:  2011-06-30       Impact factor: 22.113

3.  Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

Authors:  Steven Z Pavletic; Paul Martin; Stephanie J Lee; Sandra Mitchell; David Jacobsohn; Edward W Cowen; Maria L Turner; Gorgun Akpek; Andrew Gilman; George McDonald; Mark Schubert; Ann Berger; Peter Bross; Jason W Chien; Daniel Couriel; J P Dunn; Jane Fall-Dickson; Ann Farrell; Mary E D Flowers; Hildegard Greinix; Steven Hirschfeld; Lynn Gerber; Stella Kim; Robert Knobler; Peter A Lachenbruch; Frederick W Miller; Barbara Mittleman; Esperanza Papadopoulos; Susan K Parsons; Donna Przepiorka; Michael Robinson; Michael Ward; Bryce Reeve; Lisa G Rider; Howard Shulman; Kirk R Schultz; Daniel Weisdorf; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2006-03       Impact factor: 5.742

4.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

5.  A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Authors:  Sandra A Mitchell; David Jacobsohn; Kimberly E Thormann Powers; Paul A Carpenter; Mary E D Flowers; Edward W Cowen; Mark Schubert; Maria L Turner; Stephanie J Lee; Paul Martin; Michael R Bishop; Kristin Baird; Javier Bolaños-Meade; Kevin Boyd; Jane M Fall-Dickson; Lynn H Gerber; Jean-Pierre Guadagnini; Matin Imanguli; Michael C Krumlauf; Leslie Lawley; Li Li; Bryce B Reeve; Janine Austin Clayton; Georgia B Vogelsang; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

6.  Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

Authors:  Jeanne M Palmer; Stephanie J Lee; Xiaoyu Chai; Barry E Storer; Mary E D Flowers; Kirk R Schultz; Yoshihiro Inamoto; Corey Cutler; Joseph Pidala; Mukta Arora; David A Jacobsohn; Paul A Carpenter; Steven Z Pavletic; Paul J Martin
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-09       Impact factor: 5.742

7.  Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.

Authors:  David A Jacobsohn; Allen R Chen; Marianna Zahurak; Steven Piantadosi; Viki Anders; Javier Bolaños-Meade; Meghan Higman; Jeffrey Margolis; Michele Kaup; Georgia B Vogelsang
Journal:  J Clin Oncol       Date:  2007-09-20       Impact factor: 44.544

Review 8.  More than skin deep? Emerging therapies for chronic cutaneous GVHD.

Authors:  C J Rodgers; S Burge; J Scarisbrick; A Peniket
Journal:  Bone Marrow Transplant       Date:  2012-08-06       Impact factor: 5.483

9.  A single-center pilot validation study of a new chronic GVHD skin scoring system.

Authors:  Hildegard T Greinix; David Pohlreich; Jacqueline Maalouf; Peter Soukup; Volker Supper; Peter Kalhs; Robert M Knobler
Journal:  Biol Blood Marrow Transplant       Date:  2007-04-23       Impact factor: 5.742

Review 10.  Current issues in chronic graft-versus-host disease.

Authors:  Gérard Socié; Jerome Ritz
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

View more
  1 in total

Review 1.  Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.

Authors:  Hadir Shakshouk; Eric R Tkaczyk; Edward W Cowen; Rokea A El-Azhary; Shahrukh K Hashmi; Saad J Kenderian; Julia S Lehman
Journal:  Transplant Cell Ther       Date:  2021-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.